1-3 of 3
Angela Ogden
Close
Sort by
Journal Articles

Phase III Trial of All-Trans Retinoic Acid (ATRA) vs Daunorubicin (D) and Cytosine Arabinoside (A) as Induction Therapy and ATRA vs Observation as Maintenance Therapy for Children with Newly Diagnosed Acute Promyelocytic Leukemia (APL).

John Gregory, MD, Haesook Kim, PhD, Todd Alonzo, MD, Rob Gerbing, PhD, Angela Ogden, MD, William Woods, MD, Howard Weinstein, MD, Lois Shepherd, MD, Charles Schiffer, MD, Frederick Appelbaum, MD, Cheryl Willman, MD, Peter Wiernik, MD, Jacob Rowe, MD, Martin Tallman, MD, James Feusner, MD
Journal: Blood
Blood (2005) 106 (11): 894.
https://doi.org/10.1182/blood.V106.11.894.894
Published: 2005
Journal Articles

All- trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol: Presented in part at the 39th meeting of the American Society of Hematology, New Orleans, LA, December 1999.

Clinical Trials & Observations
Martin S. Tallman, Janet W. Andersen, Charles A. Schiffer, Frederick R. Appelbaum, James H. Feusner, William G. Woods, Angela Ogden, Howard Weinstein, Lois Shepherd, Cheryl Willman, Clara D. Bloomfield, Jacob M. Rowe, Peter H. Wiernik
Journal: Blood
Blood (2002) 100 (13): 4298–4302.
https://doi.org/10.1182/blood-2002-02-0632
Published: 2002
Journal Articles

Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome: Presented in part at the meeting of the American Society of Hematology, San Diego, CA, December 1997.

Martin S. Tallman, Janet W. Andersen, Charles A. Schiffer, Frederick R. Appelbaum, James H. Feusner, Angela Ogden, Lois Shepherd, Jacob M. Rowe, Christopher François, Richard S. Larson, Peter H. Wiernik
Journal: Blood
Blood (2000) 95 (1): 90–95.
https://doi.org/10.1182/blood.V95.1.90
Published: 2000